Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD (Q24301769)

2

0 references

C-J Kim

3

0 references

C-W Lee

4

0 references

E Kim

Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities

5

0 references

language of work or name

English

0 references

publication date

27 January 2011

0 references

published in

Oncogene

0 references

volume

30

0 references

issue

4

0 references

page(s)

471-81

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Polo-like kinases and the orchestration of cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Polo-like kinases and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Negative feedback regulation of Aurora-A via phosphorylation of Fas-associated factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Prevention of constitutive TNF receptor 1 signaling by silencer of death domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Caspase-independent cell killing by Fas-associated protein with death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Caspase-8 deficiency facilitates cellular transformation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Normal cells, but not cancer cells, survive severe Plk1 depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Polo-like kinase 1 is essential for early embryonic development and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

FADD phosphorylation is critical for cell cycle regulation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Fas-associated factor-1 mediates chemotherapeutic-induced apoptosis via death effector filament formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Plk1 docking to GRASP65 phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Polo-like kinases (Plks) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Alkylating DNA damage stimulates a regulated form of necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423

Oscillations by the p53-Mdm2 feedback loop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.423